Quest Diagnostics Incorporated (DGX)

Gross profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Gross profit (ttm) US$ in thousands 3,200,000 3,082,000 3,025,000 3,041,000 3,057,000 3,075,000 3,189,000 3,239,000 3,433,000 3,701,000 3,937,000 4,080,000 4,209,000 4,452,000 4,554,000 4,175,000 3,633,000 3,026,000 2,512,000 2,594,000
Revenue (ttm) US$ in thousands 9,872,000 9,539,000 9,346,000 9,287,000 9,252,000 9,297,000 9,488,000 9,603,000 9,883,000 10,294,000 10,582,000 10,679,000 10,788,000 11,046,000 11,058,000 10,335,000 9,437,000 8,361,000 7,531,000 7,657,000
Gross profit margin 32.41% 32.31% 32.37% 32.74% 33.04% 33.08% 33.61% 33.73% 34.74% 35.95% 37.20% 38.21% 39.02% 40.30% 41.18% 40.40% 38.50% 36.19% 33.36% 33.88%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $3,200,000K ÷ $9,872,000K
= 32.41%

The gross profit margin of Quest Diagnostics Incorporated has shown some fluctuations over the past five years, ranging from a low of 32.31% on September 30, 2024, to a high of 41.18% on June 30, 2021. Overall, the trend has been somewhat downward, moving from the peak in June 2021 to 32.41% on December 31, 2024. The margin represents the percentage of revenue that exceeds the cost of goods sold, indicating the company's ability to generate profit after accounting for direct production costs.

The decreasing trend in the gross profit margin over the period may suggest various factors affecting the company's profitability, such as increasing costs of goods sold, pricing pressures, or changes in the revenue mix. Investors and stakeholders may want to further analyze the underlying reasons for the fluctuations in the gross profit margin to assess the company's operational efficiency and overall financial health.


Peer comparison

Dec 31, 2024